SETD2 mutations in primary central nervous system tumors

by Angela N. Viaene, Mariarita Santi, Jason Rosenbaum, Marilyn M. Li, Lea F. Surrey, MacLean P. Nasrallah
Published 2018-11-01

Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors

by Milena Guidi, Laura Giunti, Anna Maria Buccoliero, Mariarita Santi, Barbara Spacca, Salvatore De Masi, Lorenzo Genitori, Iacopo Sardi
Published 2020-04-01

B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors

by Uday B. Maachani, Umberto Tosi, David J. Pisapia, Sushmita Mukherjee, Christopher S. Marnell, Julia Voronina, Daniel Martinez, Mariarita Santi, Nadia Dahmane, Zhiping Zhou, Cynthia Hawkins, Mark M. Souweidane
Published 2020-02-01

Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis

by Tao Xu, Honglai Zhang, Sung-Soo Park, Sriram Venneti, Rork Kuick, Kimberly Ha, Lowell Evan Michael, Mariarita Santi, Chiyoko Uchida, Takafumi Uchida, Ashok Srinivasan, James M. Olson, Andrzej A. Dlugosz, Sandra Camelo-Piragua, Jean-François Rual
Published 2017-03-01

Molecular and clinicopathologic features of gliomas harboring NTRK fusions

by Matthew Torre, Varshini Vasudevaraja, Jonathan Serrano, Michael DeLorenzo, Seth Malinowski, Anne-Florence Blandin, Melanie Pages, Azra H. Ligon, Fei Dong, David M. Meredith, MacLean P. Nasrallah, Craig Horbinski, Sonika Dahiya, Keith L. Ligon, Mariarita Santi, Shakti H. Ramkissoon, Mariella G. Filbin, Matija Snuderl, Sanda Alexandrescu
Published 2020-07-01

Clinical utility of custom-designed NGS panel testing in pediatric tumors

by Lea F. Surrey, Suzanne P. MacFarland, Fengqi Chang, Kajia Cao, Komal S. Rathi, Gozde T. Akgumus, Daniel Gallo, Fumin Lin, Adam Gleason, Pichai Raman, Richard Aplenc, Rochelle Bagatell, Jane Minturn, Yael Mosse, Mariarita Santi, Sarah K. Tasian, Angela J. Waanders, Mahdi Sarmady, John M. Maris, Stephen P. Hunger, Marilyn M. Li
Published 2019-05-01

SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression

by Tara T. Doucet-O’Hare, Brianna L. DiSanza, Catherine DeMarino, Abigail L. Atkinson, Jared S. Rosenblum, Lisa J. Henderson, Kory R. Johnson, Jeffrey Kowalak, Marta Garcia-Montojo, Sariah J. Allen, Brent A. Orr, Mariarita Santi, Tongguang Wang, Saeed Fathi, Myoung Hwa Lee, Kevon Sampson, Wenxue Li, Zhengping Zhuang, Avindra Nath
Published 2021-06-01